Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
BDR Pharma urges regulators to expedite manufacturing, marketing license process for remdesivir
The company informed that central and state regulatory authorities have carried out an inspection of its API manufacturing site in…
Cancer CART therapy: What are the benefits and stakes?
Debamita Chatterjee, Ex-researcher, Harvard Medical School and NYAS/MIT/European Commission Innovation Mentor elaborates how…
Dr Reddy’s signs licensing agreement with Gilead Sciences for remdesivir
Dr Reddy’s will receive technology transfer from Gilead for manufacturing of this drug and needs to do the manufacturing scale-up…
Sun Pharma presents clinical insights of ODOMZO and LEVULAN KERASTICK + BLU-U Data for skin cancer…
Analyses of long-term data confirm that the continued and clinically meaningful results of ODOMZO (sonidegib) in people with…
Pharma MSMEs ask government to extend incentives of PLI scheme
Due to incremental sales and production provisions of the PLI scheme, the MSME sector is not able to avail the desired benefits
Lupin ties up with Omron Healthcare
To strengthen respiratory disease management facilities
Medical device maker Omron Healthcare India has joined hands with…
Naari completes acquisition of ANDAs from Intas Pharmaceuticals
The portfolio acquired comprises eight US FDA approved ANDAs and two products pending approval
Naari Pharma has entered…
FDA approves drug to treat infants and children with HIV
The safety and effectiveness of Tivicay and Tivicay PD were supported by a trial that included 75 HIV-1–infected infants, children…
Sun Pharma presents insights into clinical use of ILUMYA in moderate-to-severe plaque psoriasis
Reportedly, updated cost analysis reveals ILUMYA is among the most cost-effective first-line treatments for moderate-to-severe…
Zydus Cadila inks licensing pact with Gilead for remdesivir
The licence is royalty-free until another pharma product or vaccine is approved for the treatment or prevention of COVID-19 by the…